Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cipla, Piramal Launch Sensipar Generics Amid Growing Antitrust Challenges to Amgen/Teva Settlement

Executive Summary

Amgen seeks a preliminary injunction to halt US sales by Cipla and says it will take steps to stop Piramal’s sales; in its antitrust lawsuit, Cipla alleges Amgen paid to license Teva products under the companies’ patent settlement, which resulted in Teva pulling its generic off the market shortly after launch.


Advertisement

Related Content

Big Brands Poised To Lose US Marketing Exclusivity In 2019
AbbVie's 'Unjustified' Humira Settlements Divide Market, Class Action Claims
Going Generic: Big Brands Poised To Lose Marketing Exclusivity In The US In 2019
Generic Sensipar: Cipla Challenges Legality of Amgen/Teva Patent Settlement
Launch Abbreviated: Teva Halts US Generic Sensipar Sales After Patent Deal With Amgen
Sensipar Generics: US Court Victory, FDA Approval Position Piramal For Launch
Pay-For-Delay Deals May Be Smaller After Supreme Court Okays FTC Suits

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS124910

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel